Sort
172,184 grants matching “inflammation”
Defining the role of IL-18 in atopic dermatitis
$809,010Steven Van Dyken · Washington University · R01 · FY2024 · AI
Defining the role of IL-18 in atopic dermatitis
$809,010Steven Van Dyken · Washington University · R01 · FY2025 · AI
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
$809,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2023 · HL
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
$808,999Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2024 · HL
Mechanisms of Asthma-Dietary Interventions against Environmental Triggers
$808,934Gregory B Diette · Johns Hopkins University · P01 · FY2010 · ES
Innate immune responses to tissue infection by intestinal fungi inhibit wound repair
$808,926Thaddeus S Stappenbeck · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · AI
RNA modification and innate immune activation in HIV infection
$808,844Hisashi Akiyama · Boston University Medical Campus · R01 · FY2025 · AI
Pathophysiology of Metabolically Detrimental Changes in Adipose Distribution, Adipocyte Function, and Adipose Immune Environment on Antiretroviral Therapy
$808,810John Koethe · Vanderbilt University Medical Center · R01 · FY2024 · DK
Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models
$808,786Chongzhao Ran · Massachusetts General Hospital · R01 · FY2025 · AG
Molecular effects of cannabinoids on the Blood Brain Barrier in HIV-infected brain
$808,747Maria Cecilia Garibaldi Marcondes · San Diego Biomedical Research Institute · R01 · FY2025 · DA
Mediators of Systemic Inflammation and Heart Failure Risk in the Community
$808,739Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life
$808,711Jordana B. Cohen · University Of Pennsylvania · R01 · FY2022 · AG
Lead optimization of novel ML-IAP antagonists to treat lung cancer
$808,701Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA
Multi Parametric Total-Body Imaging of Immune Activation in Post Acute Sequelae of SARS-CoV-2 (PASC)
$808,672Negar Omidvari · University Of California At Davis · R01 · FY2025 · AI
BONE MARROW MICROENVIRONMENT AND NEUROBLASTOMA PROGRESSION
$808,641Yves Declerck · Children'S Hospital Of Los Angeles · P01 · FY2010 · CA
Project 2
$808,557Jeroen Roose · University Of California, San Francisco · P01 · FY2019 · AI
Regulation of Vascular Integrity
$808,486Brant Weinstein · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Mechanisms of innate immune dysfunction in SIV/malaria co-infection in pregnancy
$808,466Jennifer Manuzak · Tulane University Of Louisiana · R01 · FY2023 · HD
New therapeutics for Shiga toxin-E. coli disease.
$808,403Fumiko Obata · University Of Maryland Baltimore · U01 · FY2011 · AI
Single-cell Analysis of Normal and Perturbed Dynamic and Spatial Biological Systems
$808,391Benedict Anchang · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Center for Novel Therapeutics for HIV-Associated Cognitive Disorders
$808,353Justin C McArthur · Johns Hopkins University · P30 · FY2016 · MH
Biophysical detection of skin changes to cue pressure injury prevention in nursing homes
$808,318Barbara M. Bates-Jensen · University Of California Los Angeles · R01 · FY2022 · NR
Comprehensive Genome Interrogation of African American Sarcoidosis Families
$808,316Courtney Montgomery · Oklahoma Medical Research Foundation · R01 · FY2016 · HL
3/9- Predictors and Mechanisms of Conversion to Psychosis
$808,262Larry J Seidman · Beth Israel Deaconess Medical Center · U01 · FY2014 · MH
Training Program in Lung Biology and Pathobiology
$808,253Dolly Mehta · University Of Illinois At Chicago · T32 · FY2022 · HL